College of Health Solutions, Arizona State University, Phoenix, AZ 85004, USA.
Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Int J Environ Res Public Health. 2023 Jul 27;20(15):6453. doi: 10.3390/ijerph20156453.
Gastrointestinal (GI) symptoms may limit performance, but their prevalence and impact among team sports athletes is not well-documented. The objective of this study was to examine the prevalence of GI symptoms in a small sample of collegiate DI American football athletes, using a survey including the Gastrointestinal Symptoms Ratings Scale (GSRS). Forty-six athletes responded to the survey and reported scores for the 15-question GSRS with additional questions about dietary habits and supplement use. A total of 44 athletes were included in the study (45% of the current roster, age: 20.7 ± 1.7 years, 50% Afro-American or black, 39% skill position, 18% NSAIDs use, and 41% reporting protein supplement use); approximately half of the athletes (52%) reported experiencing GI complaints during exercise. Two-thirds of the athletes (61%) reported at least one or more GI symptoms in general, and 50% reported at least four moderate complaints. Seven athletes (16%) reported ≥2 severe GI symptoms with 5-13 moderate complaints. The most reported symptom was stomach pain (39%, n = 17), followed by hunger pain (36%, n = 16). Athletes reporting the use of protein supplements reported a higher GSRS score (22.0 and interquartile range (IQR) 17.0-31.8) vs. athletes not reporting protein use (15.0 and IQR 15.0-19.3), = 0.001. Most athletes surveyed reported experiencing GI symptoms. A small group of these athletes reported multiple, varied, and severe symptoms that were associated with self-reported protein supplement use. In conclusion, the number of complaints varied among athletes, confirming the value of integrating the GSRS for screening purposes, and the expected need for individual dietary treatment approaches.
胃肠道（GI）症状可能会影响运动员的表现，但有关团队运动运动员中胃肠道症状的患病率和影响尚未得到充分记录。本研究的目的是使用包括胃肠道症状评分量表（GSRS）在内的调查来检查一小部分大学生 DI 美式足球运动员中胃肠道症状的患病率。46 名运动员对调查做出了回应，并报告了 15 个问题的 GSRS 得分，以及关于饮食习惯和补充剂使用的额外问题。共有 44 名运动员被纳入研究（目前名单的 45％，年龄：20.7±1.7 岁，50％为非裔美国人或黑人，39％为技能位置，18％使用非甾体抗炎药，41％报告使用蛋白质补充剂）；大约一半的运动员（52％）报告在运动时出现胃肠道不适。三分之二的运动员（61％）总体上报告至少有一种或多种胃肠道症状，而 50％的运动员报告至少有四种中度投诉。有 7 名运动员（16％）报告≥2 种严重胃肠道症状，伴有 5-13 种中度投诉。报告最多的症状是胃痛（39％，n=17），其次是饥饿痛（36％，n=16）。报告使用蛋白质补充剂的运动员的 GSRS 评分较高（22.0 和四分位距（IQR）17.0-31.8）与未报告使用蛋白质补充剂的运动员（15.0 和 IQR 15.0-19.3）相比， = 0.001。大多数接受调查的运动员报告说经历过胃肠道症状。一小部分运动员报告了多种、不同和严重的症状，这些症状与自我报告的蛋白质补充剂使用有关。总之，运动员之间的投诉数量各不相同，这证实了整合 GSRS 进行筛查的价值，以及对个性化饮食治疗方法的预期需求。
